Davis SR - Search Results

1

Testosterone in women--the clinical significance.

Davis SR, Wahlin-Jacobsen S. Davis SR, et al. Lancet Diabetes Endocrinol. 2015 Dec;3(12):980-92. doi: 10.1016/S2213-8587(15)00284-3. Epub 2015 Sep 7. Lancet Diabetes Endocrinol. 2015. PMID: 26358173 Review.

2

Testosterone effects on the breast: implications for testosterone therapy for women.

Somboonporn W, Davis SR; National Health and Medical Research Council. Somboonporn W, et al. Among authors: davis sr. Endocr Rev. 2004 Jun;25(3):374-88. doi: 10.1210/er.2003-0016. Endocr Rev. 2004. PMID: 15180949 Review.

3

The use of testosterone after menopause.

Davis SR. Davis SR. J Br Menopause Soc. 2004 Jun;10(2):65-9. doi: 10.1258/136218004774202373. J Br Menopause Soc. 2004. PMID: 15207027 Review.

4

Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Simon J, et al. J Clin Endocrinol Metab. 2005 Sep;90(9):5226-33. doi: 10.1210/jc.2004-1747. Epub 2005 Jul 12. J Clin Endocrinol Metab. 2005. PMID: 16014407 Clinical Trial.

5

Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.

Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, Bell RJ. Davis SR, et al. Menopause. 2006 Jan-Feb;13(1):37-45. doi: 10.1097/01.gme.0000168061.32917.83. Menopause. 2006. PMID: 16607097 Clinical Trial.

6

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW. Davis SR, et al. Menopause. 2006 May-Jun;13(3):387-96. doi: 10.1097/01.gme.0000179049.08371.c7. Menopause. 2006. PMID: 16735935 Clinical Trial.

7

Androgen therapy in women: what we think we know.

Drillich A, Davis SR. Drillich A, et al. Among authors: davis sr. Exp Gerontol. 2007 Jun;42(6):457-62. doi: 10.1016/j.exger.2007.02.005. Epub 2007 Feb 23. Exp Gerontol. 2007. PMID: 17407803 Review.

8

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A. Davis S, et al. Ann Intern Med. 2008 Apr 15;148(8):569-77. doi: 10.7326/0003-4819-148-8-200804150-00001. Ann Intern Med. 2008. PMID: 18413618 Clinical Trial.

9

Testosterone for low libido in postmenopausal women not taking estrogen.

Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J; APHRODITE Study Team. Davis SR, et al. N Engl J Med. 2008 Nov 6;359(19):2005-17. doi: 10.1056/NEJMoa0707302. N Engl J Med. 2008. PMID: 18987368 Free article. Clinical Trial.

10

The incidence of invasive breast cancer among women prescribed testosterone for low libido.

Davis SR, Wolfe R, Farrugia H, Ferdinand A, Bell RJ. Davis SR, et al. J Sex Med. 2009 Jul;6(7):1850-6. doi: 10.1111/j.1743-6109.2009.01289.x. Epub 2009 Apr 24. J Sex Med. 2009. PMID: 19453875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page